Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.02
+0.01000.99%
Post-market: 1.040.0200+1.96%17:19 EDT
Volume:205.63K
Turnover:209.10K
Market Cap:15.44M
PE:-1.38
High:1.05
Open:1.00
Low:0.9900
Close:1.01
52wk High:1.80
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:1.86
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:5.72
PE(LYR):-0.83

Loading ...

BioCardia Files Revised FDA De Novo Pre-Submission for Helix Catheter Clearance

Reuters
·
Yesterday

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

THOMSON REUTERS
·
Yesterday

BioCardia - FDA Targets Initial Review Within 15 Days and Feedback or Meeting Within 70 Days

THOMSON REUTERS
·
Yesterday

BioCardia - FDA Raises no Concerns Regarding Helix Safety Data or Device Performance

THOMSON REUTERS
·
Yesterday

BioCardia CEO Peter Altman Acquires $1,030 in Common Shares

Reuters
·
Yesterday

BioCardia CEO Peter Altman Acquires Common Shares Worth $1,995

Reuters
·
Sep 24

BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and Pmda Cardiamp HF Shonin Submission

THOMSON REUTERS
·
Sep 23

BioCardia - to Submit Shonin Pre-Market Application to Pmda in Q4 2026

THOMSON REUTERS
·
Sep 23

BioCardia - Market Clearance for Cardiamp in Japan Possible by Q4 2027

THOMSON REUTERS
·
Sep 23

BioCardia - to Submit De Novo Pre-Submission for Helix Cathter System to FDA This Quarter

THOMSON REUTERS
·
Sep 23

BioCardia CEO Peter Altman Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

BioCardia CEO Peter Altman Buys 800 Shares for $872

Reuters
·
Sep 05

BioCardia Price Target Maintained with a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 25

BioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target

TIPRANKS
·
Aug 24

BioCardia gets FDA confirmation of Helix meeting minutes

TIPRANKS
·
Aug 24

BioCardia Advances Helix Catheter Toward De Novo Approval

TIPRANKS
·
Aug 24

BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-on De Novo Pre-Submission for Approval

THOMSON REUTERS
·
Aug 24

BioCardia - to Submit Follow-on Pre-Submission for Helix This Quarter

THOMSON REUTERS
·
Aug 24

BioCardia Receives Nasdaq Notice on Minimum Bid Price

TIPRANKS
·
Aug 22

BioCardia Receives NASDAQ Notice for Trading Below $1 Minimum Bid Price Requirement

Reuters
·
Aug 22